维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Pupa"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	New insighls into the role of extracellular matrix during tumor onset and progression 显示文摘	Pupa SM Menard S Forti S	2002	J Cell Physiol2002，192，3：	1
2	Ectopic ex- pression of pRb2/pl30 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line 显示文摘	Pupa SM Howard CM Invernizzi AM	1999	Oncogene1999，18，3：	1
3	New insights into the role of extracellular matrix during tumor onset and progression显示文摘	Menard S Forti S	2002	J Cell Physiol2002，192，3：	1
4	New insights into the role of extracellular matrix during tumor onset and progression显示文摘	Pupa SM Menard S FortiS etal	2002	J Cell Physiol2002，192，：	1
5	An in vivo model to com- pare human leukocyte infiltration in carcinoma xenografts producing different chemokines显示文摘	Melani C Pupa SM Stoppacoaro A	1995	Int J Cancer1995，62，5：	1
6	New insights into the role of extracellular matrix during tumor onset and progression 显示文摘	Pupa S M Menard S Forti S	2002	J Cell Physiol2002，192，3：	1
7	New insights into the role of extracellular matrix durintumoronset and progression显示文摘	Pupa SM Menard S Forti S	2002	J Cell Physiol2002，192，3：	1
8	Biological and therapeutic role of HER2 in cancer显示文摘	Menard S Pupa SM Campiglio M	2003	Oncogene2003，22，42：	1
9	High-titer HER2/neu protein-specific antibody can be detected in patients with early-stage breast cancer显示文摘	Pupa SM Gralow JR	1997	J Clin Oncol1997，15，11：	1
10	Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the cerbB - 2 overexpressing SKOV3 tumor cell line 显示文摘	PUPA S M HOWARD C M INVERNIZZI A M	1999	Oncogene1999，18，3：	1
11	Ethonafide-induced cytotoxicity is mediated by topoisomerase Ⅱ inhibition in prostate cancer cells 显示文摘	Pupa A Landowshi TH Dorr RT	2007	J Pharmacol Exp Ther2007，321，：	1
12	Biologic and therapeutie role of HER2 in cancer显示文摘	Menard S Pupa S M Campiglio M	2003	Oncogene2003，22，42：	1
13	Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination显示文摘	PUPA S M INVERNIZZI A M FORTI S	2001	Gene Ther2001，8，1：	1
14	Biologic and therapeutic role of HER2 in cancer显示文摘	Menard S Pupa SM Campiglio M	2003	Oncogene2003，22，42：	1
15	Circulating osteoprotegerin and leptin levels in postmenopansal women with and without osteoporosis显示文摘	Grigorie D Neacu E Marineseu M Pupa O	2003	Rom J Intern Med2003，41，4：	1
16	New insights into the role of extracellular matrix during tumor onset and progression显示文摘	Pupa SM Menard S Forti S	2002	J Cell Physiol2002，192，3：	1
17	Biologic and therapeutic role of HER2 in cancer显示文摘	Menard S Pupa SM Campiglio M	2003	Oncogene2003，22，42：	1
18	Activity and resistance oftrastuzumab according to different clinical settings 显示文摘	Tagliabue E Campiglio M Pupa S M	2012	Cancer TreatRev2012，38，3：	1
19	Biologic and therapeutic role of HER2 in cancer 显示文摘	Menard S Pupa SM Campiglio M	2003	Oncogene2003，22，10：	1
20	High - titer HER - 2/neu pro- tein - specific antibody can be detected in patients with early - stage breast cancer显示文摘	Disis ML Pupa SM Gralow JR	1997	J Clin Oncol1997，15，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示